Ortec Targeting Late 1999 Launch Of Cultured Skin Product Under HDE
This article was originally published in The Gray Sheet
Executive Summary
Ortec International is hoping to release its Composite Cultured Skin for the management of chronic ulcers in patients with junctional and dystrophic forms of epidermolysis bullosa in late 1999 following a recent humanitarian use designation from FDA.